The Rotalex test, a commercial latex agglutination test for rotavirus, was compared with direct electron microscopy (EM) and the Rotazyme test I, a commercial enzyme immunoassay, for detection of rotavirus in stools of children and neonates. For initial stool specimens from 265 children (<3 years old) with Since the discovery of rotavirus by direct electron microscopy (EM) more than 10 years ago (3, 8) , the technique has been used routinely for diagnosis of rotavirus gastroenteritis. However, EM is not available to most hospitals, and to examine a large number of stool specimens by EM is time consuming. For these reasons, a number of immunoassays have been developed to detect rotavirus antigen in stool specimens (2, 5, 10, 12, 15, 18, 21, 22, 24) . Rotazyme (Abbott Laboratories, Diagnostics Div., North Chicago, Ill.), a commercially available enzyme immunoassay, has been evaluated extensively and found to be comparable to EM in sensitivity and specificity (6, 16) . However, the drawback to Rotazyme is that the test requires several hours to perform and, therefore, would not be cost effective for small hospitals where one or two specimens would be examined at one time. On the other hand, the latex agglutination test is much simpler and faster and has the potential of providing a diagnosis within minutes of collecting stool specimens (10, 12, 21) .
Since the discovery of rotavirus by direct electron microscopy (EM) more than 10 years ago (3, 8) , the technique has been used routinely for diagnosis of rotavirus gastroenteritis. However, EM is not available to most hospitals, and to examine a large number of stool specimens by EM is time consuming. For these reasons, a number of immunoassays have been developed to detect rotavirus antigen in stool specimens (2, 5, 10, 12, 15, 18, 21, 22, 24) . Rotazyme (Abbott Laboratories, Diagnostics Div., North Chicago, Ill.), a commercially available enzyme immunoassay, has been evaluated extensively and found to be comparable to EM in sensitivity and specificity (6, 16) . However, the drawback to Rotazyme is that the test requires several hours to perform and, therefore, would not be cost effective for small hospitals where one or two specimens would be examined at one time. On the other hand, the latex agglutination test is much simpler and faster and has the potential of providing a diagnosis within minutes of collecting stool specimens (10, 12, 21) .
Recently, a commercial latex agglutination kit has become available and is marketed as Rotalex by Orion Diagnostica of Helsinki, Finland. In this study, we evaluated the Rotalex test by comparing it with EM and Rotazyme.
MATERIALS AND METHODS Stool specimens. Three groups of stool specimens (not rectal swabs) were examined in the study: (i) initial (first available) stool specimens from children (<3 years of age) with diarrhea submitted to the microbiology laboratory of the Alberta Children's Hospital (Calgary, Alberta, Canada) for routine culture or virus examination or both; (ii) follow-up specimens from children whose initial stool specimens were positive for rotavirus by EM There were 21 specimens for which EM results (17 positive and 4 negative) did not agree with one or both of the other two tests. Of 17 EM-positive specimens, 9 were negative by both the Rotalex and Rotazyme tests, 6 were negative by Rotazyme only, and 2 were negative by Rotalex only. Of four EM-negative specimens, three were positive by Rotazyme only, and one was positive by Rotalex only. No specimen was EM negative when with the two other tests were positive.
Blocking tests were performed in 11 specimens; 5 specimens (control) were positive by all three tests, 1 was positive by EM and Rotazyme, 1 was positive by EM and Rotalex, three were positive by Rotazyme only, and 1 was positive by Rotalex only. All EM-positive specimens were positive by the confirmatory test, whereas the test was negative in the EM-negative specimen. There were another six EM-positive specimens for which only one of the other two tests was positive, but blocking tests were not done owing to insufficient quantity.
Follow-up specimens. We followed up 20 patients whose initial stool specimens were positive for rotavirus by all three tests but negative for bacterial pathogens or adenovirus to evaluate the performance of the Rotalex test during the acute and convalescent periods of illness. A total of 81 stool specimens were collected at 1 to 18 days from the onset of diarrhea, and the results were grouped into four periods (Fig.  1) . Each period was 3 days long, except the first and last periods. There was only one specimen collected on day 1 after onset, which was included in the first period, and all specimens collected on day 11 Stool specimens from newborns. Stool specimens from newborns without diarrhea were examined because a significant false-positive rate by the Rotazyme test was reported previously (7, 14) . A total of 219 specimens from 105 newborns were available ( (Table 1 ) and in none of 81 follow-up stools from children with rotavirus gastroenteritis (Fig. 1) . Although the sensitivity of the Rotalex test was 82% (49/60) for initial stool specimens, it was much higher when tested on stool specimens obtained during an early stage of rotavirus infection. Sensitivity was 100 and 96% during 1 to 4 and 5 to 7 days, respectively, after the onset of symptoms and then fell to lower levels thereafter. These findings are consistent with a previous report that the concentration of virus particles shed in stools is decreased significantly after the first week of illness in the majority of patients (13) .
The sensitivities of latex agglutination tests for rotavirus reported in the literature varied from 91 to 100% (1, 10. 11, 16, 21) . The data from our study suggest that the varying sensitivities reported could be due to different timing of stool collection relative to the onset of illness. Sensitivity of the Rotalex test on the initial stool specimens in this study was 81.7%, which is lower than on the follow-up specimens on days 1 to 7. Some of the initial specimens could have been collected in the second week or during a later period of the illness, but information was not available. We recommend that the Rotalex testing be performed for children with diarrhea seen within a week of the onset of symptoms. The Rotalex test may not be reliable in the second week of illness.
The Rotazyme tests performed on initial stools showed a sensitivity of 75.0%. which was considerably lower than those reported in other studies (1, 6, 16) . The difference in the criteria for positivity used in these studies may account for the disagreement. For example, Cheung et al. (6) reported the sensitivity of the Rotazyme test to be 91.7% when a color intensity of 1+ or greater was considered positive. However, sensitivity was reduced to 75.0% when positivity was defined the same way as in the present study, i.e., 2+ or greater. Other reasons for the difference in sensitivities observed in various studies may be that stools were collected at different times relative to the onset of diarrhea. It was shown in the present study that the sensitivity of the Rotazyme test varied, as did that of the Rotalex test, depending on the timing of stool collection during illness. Enzyme immunoassays for rotavirus have been reported to be more sensitive than EM (2, 5, 18, 24) . However, a problem we encountered in our study was that a large number of stool specimens produced a visual reading of 1 +, of which the majority were EM negative. We found the suggestion of the manufacturer that tests with a reading of 1+ be repeated on specimens collected 24 h after the first sampling to be impractical. If a reading of 1+ had been considered positive for rotavirus, the sensitivity of the Rotazyme test could have increased significantly, but false positivity would also have increased. Another problem was that the Rotazyme test kit does not include control beads coated with preimmune sera. The number of specimens with equivocal results might be reduced if these were available.
Stool specimens from asymptomatic newborns were examined by the Rotalex test because reports have indicated unreliability (15 to 20% false positivity) of the Rotazyme test performed on stool specimens from newborns (7, 14) . Our study showed a false positivity of only 4.2% (9/215) by Rotazyme and 3.3% (7/215) by the Rotalex test ( Table 2 ). The significant difference between the false positivities reported could not be explained. Regardless, we found the Rotalex test reliable in screening newborn stools for rotavirus.
The cost of the Rotalex test was about one-half to onethird of that of EM or Rotazyme. The test can be completed within 5 min for a single specimen compared with 1 h to several hours for EM or the Rotazyme test. Since the completion of this study, a new version of the Rotalex test kit has been marketed in the United States only that uses filtration rather than centrifugation for sample preparation. Vials with predispensed dilution buffer are included in the new kit, and stool suspension is clarified as it is pushed through a filtration device attached to the cap of the vial and dropped onto a test slide. The new kit may cost slightly more than the one used in this study, but it eliminates the need for a centrifuge and pipettes and may reduce turnaround time.
In conclusion, the Rotalex test was shown to be highly accurate, inexpensive, and extremely rapid in detecting rotavirus in stools. However, when the test is performed on stool specimens from the children who are in the second week of diarrheal illnesses, negative results should be confirmed by EM. The Rotalex test appears suitable for rapid diagnosis of rotavirus gastroenteritis in small hospitals, emergency wards, or even in the physician's office.
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